Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Study reveals how adiponectin may influence survival and longevity

Oct. 28, 2005

Recent patents disclose novel agents for the treatment of diabetes

Oct. 28, 2005

New agents claimed for the treatment of metabolic disorders

Oct. 28, 2005

FDA to review iPlex complete response

Oct. 27, 2005

FASgen awarded SBIR grant for work in obesity and metabolic disorders

Oct. 27, 2005

Tostrex launched in Sweden

Oct. 26, 2005

Recombinant osteoprotegerin shows potential in juvenile Paget's disease

Oct. 26, 2005

ICA-17043 induces sustained improvements in patients with sickle cell anemia

Oct. 25, 2005

Tesaglitazar improves lipids, glucose metabolism in insulin-resistant subjects

Oct. 24, 2005

Levemir approved for use in children

Oct. 24, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Regeneron’s fianlimab lags in melanoma, does $2.3B deal with Parabilis
BioWorld
Regeneron Pharmaceuticals Inc. stuck with the tradition of releasing bad news on Friday afternoon and good news on Monday morning with a pair of announcements...